CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-05 | Kelbon Marcia S. VP Patent and General Counsel | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2016-12-05 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +102,040 | $0.98 | $100K | 1,987,025 |
| 2016-12-05 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −102,040 | $10.71 | $1.1M | 1,884,985 |
| 2016-12-05 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −102,040 | 204,084 | ||
| 2016-12-05 | Demopulos Gregory A MD Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2016-12-02 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +102,040 | $0.98 | $100K | 1,805,862 |
| 2016-12-02 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −102,040 | $11.00 | $1.1M | 1,703,822 |
| 2016-12-02 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +181,163 | $0.98 | $178K | 1,884,985 |
| 2016-12-02 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −102,040 | 306,124 | ||
| 2016-12-02 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −181,163 | 0 | ||
| 2016-12-01 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +106,521 | $0.98 | $104K | 1,810,343 |
| 2016-12-01 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −105,522 | $11.56 | $1.2M | 1,704,821 |
| 2016-12-01 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −999 | $12.32 | $12K | 1,703,822 |
| 2016-12-01 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −106,521 | 408,164 | ||
| 2016-11-30 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion | +97,559 | $0.98 | $96K | 1,801,381 |
| 2016-11-30 | Demopulos Gregory A MD Chairman, CEO & President | Sale | −97,559 | $12.21 | $1.2M | 1,703,822 |
| 2016-11-30 | Demopulos Gregory A MD Chairman, CEO & President | Exercise or conversion · Stock Option (Right to Buy) | −97,559 | 514,685 | ||
| 2016-10-12 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +3,004 | $6.05 | $18K | 166,601 |
| 2016-10-12 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −3,004 | 13,040 | ||
| 2016-09-15 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +16,000 | $0.98 | $16K | 179,597 |
Page 16 of 20 · 391 trades